Tevogen Total Other Income Expense Net from 2010 to 2024

TVGNW Stock   0.04  0  12.00%   
Tevogen Bio Total Other Income Expense Net yearly trend continues to be fairly stable with very little volatility. Total Other Income Expense Net is likely to outpace its year average in 2024. During the period from 2010 to 2024, Tevogen Bio Total Other Income Expense Net regression line of quarterly data had mean square error of 25.5 T and geometric mean of  9,296,390. View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2010-12-31
Previous Quarter
6.2 M
Current Value
6.5 M
Quarterly Volatility
6.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tevogen Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tevogen Bio's main balance sheet or income statement drivers, such as Net Interest Income of 0.0, Interest Expense of 0.0 or Selling General Administrative of 1 M, as well as many indicators such as . Tevogen financial statements analysis is a perfect complement when working with Tevogen Bio Valuation or Volatility modules.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Latest Tevogen Bio's Total Other Income Expense Net Growth Pattern

Below is the plot of the Total Other Income Expense Net of Tevogen Bio Holdings over the last few years. It is Tevogen Bio's Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tevogen Bio's overall financial position and show how it may be relating to other accounts over time.
Total Other Income Expense Net10 Years Trend
Slightly volatile
   Total Other Income Expense Net   
       Timeline  

Tevogen Total Other Income Expense Net Regression Statistics

Arithmetic Mean(7,103,797)
Geometric Mean9,296,390
Coefficient Of Variation(95.52)
Mean Deviation5,241,659
Median(10,379,834)
Standard Deviation6,785,514
Sample Variance46T
Range16.9M
R-Value0.70
Mean Square Error25.5T
R-Squared0.49
Significance0
Slope1,056,985
Total Sum of Squares644.6T

Tevogen Total Other Income Expense Net History

20246.5 M
20236.2 M
20225.4 M

About Tevogen Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Tevogen Bio income statement, its balance sheet, and the statement of cash flows. Tevogen Bio investors use historical funamental indicators, such as Tevogen Bio's Total Other Income Expense Net, to determine how well the company is positioned to perform in the future. Although Tevogen Bio investors may use each financial statement separately, they are all related. The changes in Tevogen Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tevogen Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Tevogen Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Tevogen Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Other Income Expense Net6.2 M6.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tevogen Stock Analysis

When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.